It's in the 10K but nothing to get excited about. Found it interesting after all the other ties popping up over the past two years.
The 10K does contain a few interesting tidbits like the large increase of API sales to Baxalta although some claim stagnation of HyQvia sales. Increased API inventory. New API manufacturing eoy which just happens to fall in line with US approval/launch. Well worth the read with a lot of data you wont get elsewhere.